Low ineffective doses may deliver no benefit while still costing money
Testing limits It remains unclear when the Food and Drug Administration might approve new GLP-1 drugs in lower doses for children younger than 12
The regulatory environment for compounded GLP-1 medications continues to evolve, and reviewing the FDA's current public guidance before making treatment decisions is worth the time
Claassen, Rbert Bdizs, Martin Dresler, and Yevgenia Rosenblum Physiology 2025 40:3, 271-290 Nutrition state of science and dementia prevention: recommendations of the Nutrition for Dementia Prevention Working Group Yassine, Hussein N et al
If food-centric events feel overwhelming, suggest alternative activities like going for a walk in nature, which is an excellent way to naturally boost your dopamine levels
Encourages Sustainable Fat Loss: Supports gradual, maintainable body-composition changes rather than rapid, rebound-prone weight loss